Section Arrow
PODD.NASDAQ
- Insulet Corp
Quotes are at least 15-min delayed:2026/11/20 17:54 EST
After Hours
Last
 135
+1.83 (+1.37%)
Bid
131.97
Ask
137.71
High 140 
Low 132.2 
Volume 102.04K 
Regular Hours (Closed)
Last
 133.17
-4.06 (-2.96%)
Day High 
140.47 
Prev. Close
137.23 
1-M High
168.47 
Volume 
1.80M 
Bid
131.97
Ask
137.71
Day Low
132.3775 
Open
134.97 
1-M Low
134.66 
Market Cap 
9.52B 
Currency 美元 
P/E 22.42 
%Yield -- 
10-SMA 146.4 
20-SMA 149.64 
50-SMA 142.25 
52-W High 342.13 
52-W Low 126.4 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
6.12/7.32
Enterprise Value
10.45B
Balance Sheet
Book Value Per Share
22.76
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
2.71B
Operating Revenue Per Share
22.44
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 42.3233 +0.3433 +0.82%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.65 +0.02 +1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.52 -0.42 -0.42%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.93 +0.021 +2.31%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 103.53 +0.53 +0.51%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.